Advancements in drug delivery
Conventional dosage forms such as tablets and capsules remain the preferred dosage form for patients administering their medications at home. However, to overcome specific formulation challenges, including lower bioavailability, frequent application or common side effects, companies are now exploring other dosage forms, such as injectables.
Convenient administration that minimises the invasive nature of injectables is vital to ensuring the widespread and effective adoption of these products
Auto-injectors are increasingly being used within the pharmaceutical industry to deliver these products as easily as possible for patients. Simple and easy to use, auto-injectors have become the standard delivery method, mainly due to the fact they are “less invasive” than other devices, such as pre-filled syringes.
Convenient administration that minimises the invasive nature of injectables is vital to ensuring the widespread and effective adoption of these products. However, many newer parenteral formulations are viscous by nature, meaning delivery through fine needles can be difficult with conventional spring-powered auto injectors. It is therefore crucial that drug delivery device manufacturers innovate novel injection devices, such as our VapourSoft® technology, that facilitate viscous drug delivery.
In an article with World Pharma Today, our experts at Recipharm explore the reasons why solutions are needed to enable efficacious delivery of viscous drug formulations.
Click here to read the full article.